Philips Reports Q3 2026 Growth Driven by Order Intake and Margin Expansion

Philips (PHG) reported strong third-quarter 2026 results, characterized by a 3% increase in comparable sales growth and an 8% rise in equipment order intake. The company saw significant momentum in its Diagnosis and Treatment segment, which experienced nearly 20% growth in order intake, alongside steady gains in Personal Health and Connected Care sectors. Profitability improved with an adjusted EBITA margin of 13%, a 70 basis point expansion driven by productivity measures and innovation-led gross margin improvements. Free cash flow saw a substantial boost to EUR 384 million compared to the previous year. Despite these gains, the company recorded a EUR 288 million legal provision related to an agreement with the U.S. Department of Justice regarding Respironics. Management reiterated full-year sales guidance of 3% to 4.5% growth and adjusted EBITA margin guidance of 13.5% to 14%. The company continues to focus on its long-term productivity target of EUR 1.5 billion in savings by 2028, while transitioning toward recurring revenue models through 'Monitoring as a Service.'

10 articles from 3 sources · updated

Coverage